BioNTech Plans Larger Scale Closures
BioNTech management announced in Mainz today plans to close several production sites. The move is expected to affect up to 1,000 employees. The company previously acquired CureVac, a competitor based in Tübingen, last year.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
hr-iNFO
“Der Impfstoffhersteller BioNTech plant die Schließung mehrerer Produktionsstandorte. Das hat das Management des Unternehmens heute in Mainz angekündigt. Insgesamt bis zu 1.000.”
Inforadio RBB
“erst im vergangenen Jahr hat BioNTech den Tübinger Konkurrenten CureVac übernommen.”
hr-iNFO
“das Management des Unternehmens heute in Mainz angekündigt. Insgesamt bis zu 1.000.”
Inforadio RBB
“Der Bericht von Wirtschaftsreporter Thomas Wagner.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade